TerminatedNot Applicable

Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture

Stopped: Endo determined to discontinue its registries and the GRASP registry enrollment has been closed.

United States130 participantsStarted 2023-06-14

Plain-language summary

This is an observational study, meaning participants will not receive any investigational treatment as part of this study. Researchers will collect real-world data (RWD), based on usual care, to gain a more in-depth knowledge of the natural history and the treatment outcomes of Dupuytren's Contracture (DC) to evaluate the management of DC.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Key Inclusion Criteria: * Any adult with a confirmed clinical diagnosis of DC. * Age 18 years (or age of majority in their jurisdiction) or older at time of enrollment. * Willing to participate in the registry (including completion of ePROs) and complete the informed consent form. * Having received DC treatment, either non-surgical or surgical, within 2 weeks before enrollment, at enrollment or any time after the date of enrollment or not having received DC treatment after confirmed diagnosis of DC. * Able to participate in English based registry. Key Exclusion criteria: * Not having a clinical diagnosis of DC. * Age less than 18 years. * Do not provide informed consent.

What they're measuring

Number of Participants Receiving Each Treatment Type for DC

Timeframe: Up to 36 months

Trial details

NCT IDNCT05877066

SponsorEndo Pharmaceuticals

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2024-02-26

View on ClinicalTrials.gov More Dupuytren's Contracture trials